NCT03794505View on ClinicalTrials.gov

Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

August 30, 2018

Study Completion Date

August 30, 2018

Conditions
Shoulder Arthritis
Interventions
DRUG

Methylprednisolone Acetate

depo-medrol 40 mg

DRUG

Lidocaine 2% Injectable Solution

2ml of 2% lidocaine

DRUG

Ropivacaine HCl Inj 7.5 MG/ML

25 mg

Trial Locations (1)

07760

"Department of Orthopedics, UMAE Dr. Victorio de la Fuente Narváez IMSS-UNAM. Ciudad de México, México", Mexico City

All Listed Sponsors
lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT03794505 - Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis | Biotech Hunter | Biotech Hunter